Gender Specific Issues in Hereditary Ocular Disorders

References

• Usui S, Oveson BC, Lee SY, Jo YJ, Yoshida T, Miki A, et al. NADPH oxidase plays a central role in cone cell death in retinitis pigmentosa. J Neurochem 2009;110:1028–1037
   PubMed Web of Science ®Google Scholar
• Jin GF, Hurst JS, Godley BF. Hydrogen peroxide stimulates apoptosis in cultured human retinal pigment epithelial cells. Curr Eye Res 2001;22:165–173
   PubMed Web of Science ®Google Scholar
• Vingerling JR, Dielemans I, Witteman JC, Hofman A, Grobbee DE, de Jong PT. Macular degeneration and early menopause: a case-control study. BMJ 1995;310:1570–1571
   PubMed Web of Science ®Google Scholar
• Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch Ophthalmol 1992;110:1701–1708
   Google Scholar
• Khayum MA, de Vries EF, Glaudemans AW, Dierckx RA, Doorduin J. In vivo imaging of brain estrogen receptors in rats: a 16alpha-18F-fluoro-17beta-estradiol PET study. J Nucl Med 2014;55:481–487
   Google Scholar
• Azcoitia I, Yague JG, Garcia-Segura LM. Estradiol synthesis within the human brain. Neuroscience 2011;191:139–147
   PubMed Web of Science ®Google Scholar
• Vina J, Sastre J, Pallardo FV, Gambini J, Borras C. Modulation of longevity-associated genes by estrogens or phytoestrogens. Biol Chem 2008;389:273–277
   PubMed Web of Science ®Google Scholar
• Dubal DB, Wise PM. Neuroprotective effects of estradiol in middle-aged female rats. Endocrinology 2001;142:43–48
   PubMed Web of Science ®Google Scholar
• Simpkins JW, Singh M, Brock C, Etgen AM. Neuroprotection and estrogen receptors. Neuroendocrinology 2012;96:119–130
   Google Scholar
• Behl C, Widmann M, Trapp T, Holsboer F. 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 1995;216:473–482
   PubMed Web of Science ®Google Scholar
• Wickramasekera NT, Das GM. Tumor suppressor p53 and estrogen receptors in nuclear-mitochondrial communication. Mitochondrion 2013;16C:26–37
   Google Scholar
• Giordano C, Montopoli M, Perli E, Orlandi M, Fantin M, Ross-Cisneros FN, et al. Oestrogens ameliorate mitochondrial dysfunction in Leber's hereditary optic neuropathy. Brain 2011;134:220–234
   PubMed Web of Science ®Google Scholar
• Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res 2004;23:53–89
   PubMed Web of Science ®Google Scholar
• Badura-Stronka M, Wawrocka A, Zawieja K, Silska S, Krawczynski MR. Severe manifestation of Leber's hereditary optic neuropathy due to 11778G>A mtDNA mutation in a female with hypoestrogenism due to Perrault syndrome. Mitochondrion 2013;13:831–834
   PubMed Web of Science ®Google Scholar
• Kim MJ, Kim SJ, Kim J, Chae H, Kim M, Kim Y. Genotype and phenotype heterogeneity in perrault syndrome. J Pediatr Adolesc Gynecol 2013;26:e25–7
   PubMedGoogle Scholar
• Gupta PD, Kalariya N, Nagpal K, Vasavada A. Pinteraction of sex steroid hormones with the eye. Cell Mol Biol (Noisy-le-grand) 2002;48:379–386
   Google Scholar
• Athanasiou D, Aguila M, Bevilacqua D, Novoselov SS, Parfitt DA, Cheetham ME. The cell stress machinery and retinal degeneration. FEBS Lett 2013;587:2008–2017
   Google Scholar
• Li S, Yang Z, Hu J, Gordon WC, Bazan NG, Haas AL, et al. Secretory defect and cytotoxicity: the potential disease mechanisms for the retinitis pigmentosa (RP)-associated interphotoreceptor retinoid-binding protein (IRBP). J Biol Chem 2013;288:11395–11406
   PubMed Web of Science ®Google Scholar
• Lin JH, Lavail MM. Misfolded proteins and retinal dystrophies. Adv Exp Med Biol 2010;664:115–121
   PubMed Web of Science ®Google Scholar
• Engler C, Kelliher C, Spitze AR, Speck CL, Eberhart CG, Jun AS. Unfolded protein response in fuchs endothelial corneal dystrophy: a unifying pathogenic pathway? Am J Ophthalmol 2010;149:194–202 e2
   Google Scholar
• Jun AS, Meng H, Ramanan N, Matthaei M, Chakravarti S, Bonshek R, et al. An alpha 2 collagen VIII transgenic knock-in mouse model of Fuchs endothelial corneal dystrophy shows early endothelial cell unfolded protein response and apoptosis. Hum Mol Genet 2012;21:384–393
   PubMedGoogle Scholar
• Meng H, Matthaei M, Ramanan N, Grebe R, Chakravarti S, Speck CL, et al. L450W and Q455K Col8a2 knock-in mouse models of Fuchs endothelial corneal dystrophy show distinct phenotypes and evidence for altered autophagy. Invest Ophthalmol Vis Sci 2013;54:1887–1897
   PubMed Web of Science ®Google Scholar
• Dioufa N, Kassi E, Papavassiliou AG, Kiaris H. Atypical induction of the unfolded protein response by mifepristone. Endocrine 2010;38:167–173
   Google Scholar
• Aghazadeh Y, Rone MB, Blonder J, Ye X, Veenstra TD, Hales DB, et al. Hormone-induced 14-3-3gamma adaptor protein regulates steroidogenic acute regulatory protein activity and steroid biosynthesis in MA-10 Leydig cells. J Biol Chem 2012;287:15380–15394
   Google Scholar
• Guzel E, Basar M, Ocak N, Arici A, Kayisli UA. Bidirectional interaction between unfolded-protein-response key protein HSPA5 and estrogen signaling in human endometrium. Biol Reprod 2011;85:121–127
   Google Scholar
• Haas MJ, Raheja P, Jaimungal S, Sheikh-Ali M, Mooradian AD. Estrogen-dependent inhibition of dextrose-induced endoplasmic reticulum stress and superoxide generation in endothelial cells. Free Radic Biol Med 2012;52:2161–2167
   PubMedGoogle Scholar
• Ishii Y, Papa L, Bahadur U, Yue Z, Aguirre-Ghiso J, Shioda T, et al. Bortezomib enhances the efficacy of fulvestrant by amplifying the aggregation of the estrogen receptor, which leads to a proapoptotic unfolded protein response. Clin Cancer Res 2011;17:2292–2300
   Google Scholar
• Periyasamy-Thandavan S, Jackson WH, Samaddar JS, Erickson B, Barrett JR, Raney L, et al. Bortezomib blocks the catabolic process of autophagy via a cathepsin-dependent mechanism, affects endoplasmic reticulum stress and induces caspase-dependent cell death in antiestrogen-sensitive and resistant ER+ breast cancer cells. Autophagy 2010;6:19–35
   PubMed Web of Science ®Google Scholar
• D'Anna C, Cascio C, Cigna D, Galizzi G, Deidda I, Bianchi L, et al. A retinal proteomics-based study identifies alphaA-crystallin as a sex steroid-regulated protein. Proteomics 2011;11:986–990
   Google Scholar
• Wuthisiri W, Lingao MD, Capasso JE, Levin AV. Lyonization in ophthalmology. Curr Opin Ophthalmol 2013;24:389–397
   Google Scholar
• Cotton AM, Chen CY, Lam LL, Wasserman WW, Kobor MS, Brown CJ. Spread of X-chromosome inactivation into autosomal sequences: role for DNA elements, chromatin features and chromosomal domains. Hum Mol Genet 2013;23:1211–1223
   Google Scholar
• Okamoto I, Otte AP, Allis CD, Reinberg D, Heard E. Epigenetic dynamics of imprinted X inactivation during early mouse development. Science 2004;303:644–649
   PubMed Web of Science ®Google Scholar
• Tan SS, Williams EA, Tam PP. X-chromosome inactivation occurs at different times in different tissues of the post-implantation mouse embryo. Nat Genet 1993;3:170–174
   PubMed Web of Science ®Google Scholar
• Wu H. Cellular resolution maps of X chromosome inactivation: implications for neuronal development, function, and disease. Neuron 2014;81:103--119
   Google Scholar
• Busque L, Mio R, Mattioli J, Brais E, Blais N, Lalonde Y, et al. Nonrandom X-inactivation patterns in normal females: lyonization ratios vary with age. Blood 1996;88:59–65
   PubMed Web of Science ®Google Scholar
• Neidich JA, Nussbaum RL, Packer RJ, Emanuel BS, Puck JM. Heterogeneity of clinical severity and molecular lesions in Aircardi syndrome. J Pediatr 1990;116:911–917
   Google Scholar
• Dobyns WB, Filauro A, Tomson BN, Chan AS, Ho AW, Ting NT, et al. Inheritance of most X-linked traits is not dominant or recessive, just X-linked. Am J Med Genet A 2004;129A:136–143
   PubMed Web of Science ®Google Scholar
• Polychronakos C, Kukuvitis A. Parental genomic imprinting in endocrinopathies. Eur J Endocrinol 2002;147:561–9
   Google Scholar
• Arnaud P, Feil R. Epigenetic deregulation of genomic imprinting in human disorders and following assisted reproduction. Birth Defects Res C Embryo Today 2005;75:81–97
   Google Scholar
• Clayton-Smith J. Genomic imprinting as a cause of disease. BMJ 2003;327:1121–1122
   Google Scholar
• Lidegaard O, Pinborg A, Andersen AN. Imprinting disorders after assisted reproductive technologies. Curr Opin Obstet Gynecol 2006;18:293–296
   PubMed Web of Science ®Google Scholar
• Tomizawa S, Sasaki H. Genomic imprinting and its relevance to congenital disease, infertility, molar pregnancy and induced pluripotent stem cell. J Hum Genet 2012;57:84–91
   Google Scholar
• Roosing S, van den Born LI, Hoyng CB, Thiadens AA, de Baere E, Collin RW, et al. Maternal uniparental isodisomy of chromosome 6 reveals a TULP1 mutation as a novel cause of cone dysfunction. Ophthalmology 2013;120:1239–1246
   PubMed Web of Science ®Google Scholar
• Quan F, Janas J, Toth-Fejel S, Johnson DB, Wolford JK, Popovich BW. Uniparental disomy of the entire X chromosome in a female with Duchenne muscular dystrophy. Am J Hum Genet 1997;60:160–165
   PubMed Web of Science ®Google Scholar
• Samra KA. The eye and visual system in pregnancy, what to expect? An in-depth review. Oman J Ophthalmol 2013;6:87–91
   PubMedGoogle Scholar
• Hendersen RH. Retinitis punctata albescens and retinitis pigmentosa affected by pregnancy. JAMA 1934;11:763--768
   Google Scholar
• Vingolo EM, Salvatore S, Stagnitti F. Visual acuity changes in retinitis pigmentosa during pregnancy. Int J Gynecol Obstet 2009;105:269
   Google Scholar
• Berde C, Willis DC, Sandberg EC. Pregnancy in women with pseudoxanthoma elasticum. Obstet Gynecol Surv 1983;38:339–344
   PubMedGoogle Scholar
• Farhi D, Descamps V, Picard C, Mahieu-Caputo D, Doan S, Crickx B. Is pseudoxanthoma elasticum with severe angioid streaks an indication for Caesarean section? J Eur Acad Dermatol Venereol 2006;20:1361–1362
   Google Scholar
• Yuan SM. Postpartum aortic dissection. Taiwan J Obstet Gynecol 2013;52:318–322
   Google Scholar
• Omnes S, Jondeau G, Detaint D, Dumont A, Yazbeck C, Guglielminotti J, et al. Pregnancy outcomes among women with Marfan syndrome. Int J Gynaecol Obstet 2013;122:219–223
   PubMed Web of Science ®Google Scholar
• Schoenhoff F, Schmidli J, Czerny M, Carrel TP. Management of aortic aneurysms in patients with connective tissue disease. J Cardiovasc Surg (Torino) 2013;54:125–134
   Google Scholar
• Allyn J, Guglielminotti J, Omnes S, Guezouli L, Egan M, Jondeau G, et al. Marfan's syndrome during pregnancy: anesthetic management of delivery in 16 consecutive patients. Anesth Analg 2013;116:392–398
   PubMed Web of Science ®Google Scholar
• Katsuragi S, Ueda K, Yamanaka K, Neki R, Kamiya C, Sasaki Y, et al. Pregnancy-associated aortic dilatation or dissection in Japanese women with Marfan syndrome. Circ J 2011;75:2545–2551
   PubMed Web of Science ®Google Scholar
• Houston L, Tuuli M, Macones G. Marfan syndrome and aortic dissection in pregnancy. Obstet Gynecol 2011;117:956–960
   PubMed Web of Science ®Google Scholar
• Chetty SP, Shaffer BL, Norton ME. Management of pregnancy in women with genetic disorders, Part 1: Disorders of the connective tissue, muscle, vascular, and skeletal systems. Obstet Gynecol Surv 2011;66:699–709
   Google Scholar
• Palmquist M, Pappas JG, Petrikovsky B, Blakemore K, Roshan D. Successful pregnancy outcome in Ehlers-Danlos syndrome, vascular type. J Matern Fetal Neonatal Med 2009;22:924–927
   PubMed Web of Science ®Google Scholar
• Hayden MG, Gephart R, Kalanithi P, Chou D. Von Hippel-Lindau disease in pregnancy: a brief review. J Clin Neurosci 2009;16:611–613
   PubMed Web of Science ®Google Scholar
• Inamasu J, Nichols TA, Guiot BH. Vertebral hemangioma symptomatic during pregnancy treated by posterior decompression, intraoperative vertebroplasty, and segmental fixation. J Spinal Disord Tech 2006;19:451–454
   Google Scholar
• Kolomeyevskaya N, Blazo M, Van den Veyver I, Strehlow S, Aagaard-Tillery KM. Pheochromocytoma and Von Hippel-Lindau in pregnancy. Am J Perinatol 2010;27:257–263
   Google Scholar
• Joffe D, Robbins R, Benjamin A. Caesarean section and phaeochromocytoma resection in a patient with Von Hippel Lindau disease. Can J Anaesth 1993;40:870–874
   Google Scholar
• Spoerl E, Zubaty V, Raiskup-Wolf F, Pillunat LE. Oestrogen-induced changes in biomechanics in the cornea as a possible reason for keratectasia. Br J Ophthalmol 2007;91:1547–1550
   PubMed Web of Science ®Google Scholar
• Romero-Jimenez M, Santodomingo-Rubido J, Wolffsohn JS. Keratoconus: a review. Cont Lens Anterior Eye 2010;33:157–166 (quiz 205)
   PubMed Web of Science ®Google Scholar
• Rabinowitz YS. Keratoconus. Surv Ophthalmol 1998;42:297–319
   PubMed Web of Science ®Google Scholar
• Tachibana M, Adachi W, Kinoshita S, Kobayashi Y, Honma Y, Hiai H, et al. Androgen-dependent hereditary mouse keratoconus: linkage to an MHC region. Invest Ophthalmol Vis Sci 2002;43:51–57
   PubMedGoogle Scholar
• Soeters N, Tahzib NG, Bakker L, Van der Lelij A. Two cases of keratoconus diagnosed after pregnancy. Optom Vis Sci 2012;89:112–116
   Web of Science ®Google Scholar
• Bilgihan K, Hondur A, Sul S, Ozturk S. Pregnancy-induced progression of keratoconus. Cornea 2011;30:991–994
   PubMed Web of Science ®Google Scholar
• Makieva S, Saunders PT, Norman JE. Androgens in pregnancy: roles in parturition. Hum Reprod Update 2014;20:542–559
   PubMed Web of Science ®Google Scholar
• Pearlman JT, Saxton J. Letter: retinitis pigmentosa and birth control pills. JAMA 1975;231:810
   Web of Science ®Google Scholar
• Doonan F, O'Driscoll C, Kenna P, Cotter TG. Enhancing survival of photoreceptor cells in vivo using the synthetic progestin Norgestrel. J Neurochem 2011;118:915–927
   PubMed Web of Science ®Google Scholar
• Doonan F, Cotter TG. Norgestrel may be a potential therapy for retinal degenerations. Expert Opin Investig Drugs 2012;21:579–581
   PubMed Web of Science ®Google Scholar
• Adams NA, Awadein A, Toma HS. The retinal ciliopathies. Ophthalmic Genet 2007;28:113–25
   PubMed Web of Science ®Google Scholar
• Aloulou H, Cheikhrouhou H, Belguith N, Ben Ameur S, Ben Mansour L, Chabchoub I, et al. [Bardet - Biedl syndrome in the child. A study of 11 cases]. Tunis Med 2011;89:31–36
   Google Scholar
• Mozaffarian G, Nakhjavani MK, Farrahi A. The Laurence-Moon-Bardet-Biedl syndrome: unresponsiveness to the action of testosterone, a possible mechanism. Fertil Steril 1979;31:417–422
   Google Scholar
• Sebag J, Albert DM, Craft JL. The Alstrom syndrome: ophthalmic histopathology and retinal ultrastructure. Br J Ophthalmol 1984;68:494–501
   PubMed Web of Science ®Google Scholar
• van Aarem A, Wagenaar M, Tonnaer E, Pieke Dahl S, Bisseling J, Janssen H, et al. Semen analysis in the Usher syndrome type 2A. ORL J Otorhinolaryngol Relat Spec 1999;61:126–130
   Google Scholar
• Malekpour M, Shahidi A, Khorsandi Ashtiani MT, Motasaddi Zarandy M. Novel syndrome of cataracts, retinitis pigmentosa, late onset deafness and sperm abnormalities: a new Usher syndrome subtype with X-linked inheritance? Am J Med Genet A 2007;143A:1646–1652
   Google Scholar
• Brunner S, Colman D, Travis AJ, Luhmann UF, Shi W, Feil S, et al. Overexpression of RPGR leads to male infertility in mice due to defects in flagellar assembly. Biol Reprod 2008;79:608–617
   PubMedGoogle Scholar
• Bishai R, Arbour L, Lyons C, Koren G. Intrauterine exposure to clomiphene and neonatal persistent hyperplastic primary vitreous. Teratology 1999;60:143–145
   PubMedGoogle Scholar
• Dhaliwal LK, Suri V, Gupta KR, Sahdev S. Tamoxifen: An alternative to clomiphene in women with polycystic ovary syndrome. J Hum Reprod Sci 2011;4:76–79
   PubMedGoogle Scholar
• Eisner A, Luoh SW. Breast cancer medications and vision: effects of treatments for early-stage disease. Curr Eye Res 2011;36:867–885
   PubMed Web of Science ®Google Scholar
• Padma-Nathan H. Sildenafil citrate (Viagra) treatment for erectile dysfunction: An updated profile of response and effectiveness. Int J Impot Res 2006;18:423–431
   PubMed Web of Science ®Google Scholar
• Morales A, Gingell C, Collins M, Wicker PA, Osterloh IH. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction. Int J Impot Res 1998;10:69–73 (discussion -4)
   PubMed Web of Science ®Google Scholar
• Behn D, Potter MJ. Sildenafil-mediated reduction in retinal function in heterozygous mice lacking the gamma-subunit of phosphodiesterase. Invest Ophthalmol Vis Sci 2001;42:523–527
   PubMed Web of Science ®Google Scholar
• Crawford ED. Epidemiology of prostate cancer. Urology 2003;62:3–12
   PubMed Web of Science ®Google Scholar
• Hammond LA, Brown G, Keedwell RG, Durham J, Chandraratna RA. The prospects of retinoids in the treatment of prostate cancer. Anticancer Drugs 2002;13:781–790
   PubMed Web of Science ®Google Scholar
• Pasquali D, Thaller C, Eichele G. Abnormal level of retinoic acid in prostate cancer tissues. J Clin Endocrinol Metab 1996;81:2186–2191
   Google Scholar
• Thaller C, Shalev M, Frolov A, Eichele G, Thompson TC, Williams RH, et al. Fenretinide therapy in prostate cancer: effects on tissue and serum retinoid concentration. J Clin Oncol 2000;18:3804–3808
   PubMed Web of Science ®Google Scholar
• Moore MM, Stockler M, Lim R, Mok TS, Millward M, Boyer MJ. A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group. Cancer Chemother Pharmacol 2010;66:845–850
   PubMedGoogle Scholar
• Tokar EJ, Ancrile BB, Ablin RJ, Webber MM. Cholecalciferol (vitamin D3) and the retinoid N-(4-hydroxyphenyl)retinamide (4-HPR) are synergistic for chemoprevention of prostate cancer. J Exp Ther Oncol 2006;5:323–333
   Google Scholar
• Carr AJ, Vugler AA, Yu L, Semo M, Coffey P, Moss SE, et al. The expression of retinal cell markers in human retinal pigment epithelial cells and their augmentation by the synthetic retinoid fenretinide. Mol Vis 2011;17:1701–1715
   Google Scholar
• Marmor MF, Jain A, Moshfeghi D. Total rod ERG suppression with high dose compassionate Fenretinide usage. Doc Ophthalmol 2008;117:257–261
   Google Scholar
• Deeb SS, Motulsky AG. Red-green color vision defects. In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K, editors. GeneReviews. Seattle WA: University of Washington, Seattle; 1993, 369–377
   Google Scholar
• Deeb SS. The molecular basis of variation in human color vision. Clin Genet 2005;67:369–377
   Google Scholar
• Birch J. Worldwide prevalence of red-green color deficiency. J Opt Soc Am A Opt Image Sci Vis 2012;29:313–320
   PubMed Web of Science ®Google Scholar
• Phelan JK, Bok D. A brief review of retinitis pigmentosa and the identified retinitis pigmentosa genes. Mol Vis 2000;6:116–124
   PubMed Web of Science ®Google Scholar
• Wang F, Wang H, Tuan HF, Nguyen DH, Sun V, Keser V, et al. Next generation sequencing-based molecular diagnosis of retinitis pigmentosa: identification of a novel genotype-phenotype correlation and clinical refinements. Hum Genet 2013;133:331–345
   Google Scholar
• Chizzolini M, Galan A, Milan E, Sebastiani A, Costagliola C, Parmeggiani F. Good epidemiologic practice in retinitis pigmentosa: from phenotyping to biobanking. Curr Genomics 2011;12:260–266
   PubMed Web of Science ®Google Scholar
• Wu DM, Khanna H, Atmaca-Sonmez P, Sieving PA, Branham K, Othman M, et al. Long-term follow-up of a family with dominant X-linked retinitis pigmentosa. Eye (Lond) 2010;24:764–774
   PubMed Web of Science ®Google Scholar
• Ferrari S, Di Iorio E, Barbaro V, Ponzin D, Sorrentino FS, Parmeggiani F. Retinitis pigmentosa: genes and disease mechanisms. Curr Genomics 2011;12:238–249
   PubMed Web of Science ®Google Scholar
• Souied E, Segues B, Ghazi I, Rozet JM, Chatelin S, Gerber S, et al. Severe manifestations in carrier females in X linked retinitis pigmentosa. J Med Genet 1997;34:793–797
   PubMed Web of Science ®Google Scholar
• Bech-Hansen NT, Pearce WG. X-linked retinitis pigmentosa: re-evaluation of fundus findings and the use of haplotype analysis in clarification of carrier female status. Ophthalmic Genet 1995;16:113–118
   PubMed Web of Science ®Google Scholar
• Grover S, Fishman GA, Anderson RJ, Lindeman M. A longitudinal study of visual function in carriers of X-linked recessive retinitis pigmentosa. Ophthalmology 2000;107:386–396
   PubMed Web of Science ®Google Scholar
• Schatz P, Bregnhoj J, Arvidsson H, Sharon D, Mizrahi-Meissonnier L, Sander B, et al. A tapetal-like fundus reflex in a healthy male: evidence against a role in the pathophysiology of retinal degeneration? Mol Vis 2012;18:1147–1155
   Web of Science ®Google Scholar
• Jacobson SG, Yagasaki K, Feuer WJ, Roman AJ. Interocular asymmetry of visual function in heterozygotes of X-linked retinitis pigmentosa. Exp Eye Res 1989;48:679–691
   PubMed Web of Science ®Google Scholar
• Coussa RG, Traboulsi EI. Choroideremia: a review of general findings and pathogenesis. Ophthalmic Genet 2012;33:57–65
   PubMed Web of Science ®Google Scholar
• Minic S, Obradovic M, Kovacevic I, Trpinac D. Ocular anomalies in incontinentia pigmenti: literature review and meta-analysis. Srp Arh Celok Lek 2010;138:408–13
   Google Scholar
• Ardelean D, Pope E. Incontinentia pigmenti in boys: a series and review of the literature. Pediatr Dermatol 2006;23:523–527
   Google Scholar
• Kenwrick S, Woffendin H, Jakins T, Shuttleworth SG, Mayer E, Greenhalgh L, et al. Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome. Am J Hum Genet 2001;69:1210–1217
   PubMed Web of Science ®Google Scholar
• Gregersen PA, Sommerlund M, Ramsing M, Gjorup H, Rasmussen AA, Aggerholm A. diagnostic and molecular genetic challenges in male incontinentia pigmenti: a case report. Acta Derm Venereol 2013;93:741–742
   Google Scholar
• Shen B, Samaraweera P, Rosenberg B, Orlow SJ. Ocular albinism type 1: more than meets the eye. Pigment Cell Res 2001;14:243–248
   PubMedGoogle Scholar
• Sjodell L, Sjostrom A, Abrahamsson M. Transillumination of iris and subnormal visual acuity–ocular albinism? Br J Ophthalmol 1996;80:617–623
   Google Scholar
• Charles SJ, Moore AT, Grant JW, Yates JRW. Genetic counselling in X-linked ocular albinism: Clinical features of the carrier state. Eye 1992;6:75–79
   PubMed Web of Science ®Google Scholar
• Loi M. Lowe syndrome. Orphanet J Rare Dis 2006;1:16
   PubMed Web of Science ®Google Scholar
• Brown N, Gardner RJ. Lowe syndrome: identification of the carrier state. Birth Defects Orig Artic Ser 1976;12:579–595
   Google Scholar
• Heckenlively JR, Solish AM, Chant SM, Meyers-Elliott RH. Autoimmunity in hereditary retinal degenerations. II. Clinical studies: antiretinal antibodies and fluorescein angiogram findings. Br J Ophthalmol 1985;69:758–764
   PubMed Web of Science ®Google Scholar
• Pan CW, Ramamurthy D, Saw SM. Worldwide prevalence and risk factors for myopia. Ophthalmic Physiol Opt 2012;32:3–16
   PubMed Web of Science ®Google Scholar
• Pan CW, Cheung CY, Aung T, Cheung CM, Zheng YF, Wu RY, et al. Differential associations of myopia with major age-related eye diseases: the Singapore Indian Eye Study. Ophthalmology 2013;120:284–291
   PubMed Web of Science ®Google Scholar
• Hyman L, Gwiazda J, Hussein M, Norton TT, Wang Y, Marsh-Tootle W, et al. Relationship of age, sex, and ethnicity with myopia progression and axial elongation in the correction of myopia evaluation trial. Arch Ophthalmol 2005;123:977–987
   PubMedGoogle Scholar
• Braun CI, Freidlin V, Sperduto RD, Milton RC, Strahlman ER. The progression of myopia in school age children: data from the Columbia Medical Plan. Ophthalmic Epidemiol 1996;3:13–21
   PubMedGoogle Scholar
• French AN, Morgan IG, Mitchell P, Rose KA. Patterns of myopigenic activities with age, gender and ethnicity in Sydney schoolchildren. Ophthalmic Physiol Opt 2013;33:318–328
   PubMed Web of Science ®Google Scholar
• Morgan IG, Ohno-Matsui K, Saw SM. Myopia. Lancet 2012;379:1739–1748
   PubMed Web of Science ®Google Scholar
• Chen ZT, Wang IJ, Liao YT, Shih YF, Lin LL. Polymorphisms in steroidogenesis genes, sex steroid levels, and high myopia in the Taiwanese population. Mol Vis 2011;17:2297–2310
   PubMed Web of Science ®Google Scholar
• Efe YK, Ugurbas SC, Alpay A, Ugurbas SH. The course of corneal and intraocular pressure changes during pregnancy. Can J Ophthalmol 2012;47:150–154
   PubMed Web of Science ®Google Scholar
• Battaglia C, Mancini F, Regnani G, Persico N, Volpe A, De Aloysio D. Hormone therapy and ophthalmic artery blood flow changes in women with primary open-angle glaucoma. Menopause 2004;11:69–77
   PubMed Web of Science ®Google Scholar
• Newman-Casey PA, Talwar N, Nan B, Musch DC, Pasquale LR, Stein JD. The potential association between postmenopausal hormone use and primary open-angle glaucoma. JAMA Ophthalmol 2014;132:298–303
   PubMed Web of Science ®Google Scholar
• Vajaranant TS, Grossardt BR, Maki PM, Pasquale LR, Sit AJ, Shuster LT, et al. Risk of glaucoma after early bilateral oophorectomy. Menopause 2014;21:391–398
   PubMed Web of Science ®Google Scholar
• Higginbotham EJ. Does sex matter in glaucoma? Arch Ophthalmol 2004;122:374–375
   Google Scholar
• Mark HH. Gender differences in glaucoma and ocular hypertension. Arch Ophthalmol 2005;123:284; author reply
   Google Scholar
• Pasquale LR, Loomis SJ, Weinreb RN, Kang JH, Yaspan BL, Bailey JC, et al. Estrogen pathway polymorphisms in relation to primary open angle glaucoma: an analysis accounting for gender from the United States. Mol Vis 2013;19:1471–1481
   PubMed Web of Science ®Google Scholar
• Edwards DR, Gallins P, Polk M, Ayala-Haedo J, Schwartz SG, Kovach JL, et al. Inverse association of female hormone replacement therapy with age-related macular degeneration and interactions with ARMS2 polymorphisms. Invest Ophthalmol Vis Sci 2010;51:1873–1879
   PubMed Web of Science ®Google Scholar
• Boekhoorn SS, Vingerling JR, Uitterlinden AG, Van Meurs JB, van Duijn CM, Pols HA, et al. Estrogen receptor alpha gene polymorphisms associated with incident aging macula disorder. Invest Ophthalmol Vis Sci 2007;48:1012–1017
   PubMedGoogle Scholar
• Velilla S, Garcia-Medina JJ, Garcia-Layana A, Dolz-Marco R, Pons-Vazquez S, Pinazo-Duran MD, et al. Smoking and Age-Related Macular Degeneration: Review and Update. J Ophthalmol 2013;2013:895147
   PubMed Web of Science ®Google Scholar
• Funatogawa I, Funatogawa T, Yano E. Trends in smoking and lung cancer mortality in Japan, by birth cohort, 1949–2010. Bull World Health Organ 2013;91:332–340
   PubMed Web of Science ®Google Scholar
• Arbour KP, Latimer AE, Martin Ginis KA, Jung ME. Moving beyond the stigma: the impression formation benefits of exercise for individuals with a physical disability. Adapt Phys Activ Q 2007;24:144–159
   PubMed Web of Science ®Google Scholar
• Martins AJ, Cardoso MH, Llerena JC Jr, Moreira MC. Family and religious traditions present in medical discourses by medical professionals about children with genetic diseases. Cien Saude Colet 2012;17:545–553
   Google Scholar
• Renner AB, Fiebig BS, Cropp E, Weber BH, Kellner U. Progression of retinal pigment epithelial alterations during long-term follow-up in female carriers of choroideremia and report of a novel CHM mutation. Arch Ophthalmol 2009;127:907–912
   PubMedGoogle Scholar
• Available from: http://www.mrcophth.com/pd/alba.html
   Google Scholar